ArticleEcancermedicalscience2020

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation-a case report.

Gunjesh Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.